The Clinical Efficacy of Immunomodulators in RA Patients

NCT05626348 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Iguratimod
DRUG: Methotrexate
DRUG: Adalimumab Injection
DRUG: Leflunomide
DRUG: Hydroxychloroquine

Sponsor

Qilu Hospital of Shandong University